eosinophilic esophagitis

Takeda’s Eohilia to compete Sanofi’s Dupixent in eosinophilic esophagitis treatment
Clinical Trials Arena
Thu, 02/29/24 - 11:11 am
Takeda
Eohilia
Sanofi
Dupixent
EoE
eosinophilic esophagitis
FDA approves Takeda's therapy for allergic inflammation in esophagus
Reuters
Mon, 02/12/24 - 10:21 am
Takeda
FDA
Eohilia
eosinophilic esophagitis
Sanofi reports positive data from Phase III trial of Dupixent
Clinical Trials Arena
Tue, 10/24/23 - 09:51 am
Sanofi
clinical trials
Dupixent
eosinophilic esophagitis
pediatric
Weak data for Fasenra undermine AZ’s ambitions for the drug
Pharmaphorum
Tue, 10/25/22 - 10:35 am
AstraZeneca
Fasenra
eosinophilic asthma
chronic rhinosinusitis with nasal polyps
eosinophilic esophagitis
Dupixent Shows Promise as First Treatment for Childhood EoE
BioSpace
Wed, 10/12/22 - 10:33 am
Dupixent
Sanofi
Regeneron
pediatric
clinical trials
eosinophilic esophagitis
Regeneron, Sanofi Look to Extend Dupixent into Young Kids with Eosinophilic Esophagitis
BioSpace
Thu, 07/14/22 - 11:49 am
Regeneron
Sanofi
Dupixent
pediatric
eosinophilic esophagitis
Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA
Motley Fool
Mon, 06/27/22 - 10:12 am
Sanofi
Regeneron
FDA
Dupixent
eosinophilic esophagitis
Sanofi's Dupixent scores big as the first FDA-approved treatment for eosinophilic esophagitis
Fierce Pharma
Sun, 05/22/22 - 09:15 pm
Sanofi
Regeneron
Dupixent
FDA
eosinophilic esophagitis
FDA accepts Regeneron, Sanofi’s Dupixent for priority review
Pharmaceutical Business Review
Tue, 04/5/22 - 10:53 am
Regeneron
Sanofi
Dupixent
FDA
eosinophilic esophagitis
Sanofi chases fourth Dupixent nod after late-stage eosinophilic esophagitis trial win
Fierce Pharma
Mon, 02/28/22 - 11:42 pm
Sanofi
Regeneron
eosinophilic esophagitis
Dupixent
clinical trials
With Sanofi's mighty Dupixent chasing behind, Takeda's Eohilia suffers FDA rejection after mysterious delay
Fierce Pharma
Wed, 12/22/21 - 11:11 am
Takeda
Eohilia
Sanofi
Dupixent
FDA
eosinophilic esophagitis
Sanofi, Regeneron gear up for new Dupixent filing after clearing second PhIII for eosinophilic esophagitis
Endpoints
Mon, 10/25/21 - 10:48 am
Sanofi
Regeneron
Dupixent
eosinophilic esophagitis
clinical trials
Eohilia maker Takeda targets doctors in a first-time eosinophilic esophagitis awareness push
Fierce Pharma
Wed, 03/31/21 - 10:49 am
Takeda
eosinophilic esophagitis
drug marketing
Sanofi, Regeneron chase 4th Dupixent approval with rare esophageal disease data
Fierce Pharma
Mon, 10/26/20 - 11:04 pm
Sanofi
Regeneron
FDA
Dupixent
eosinophilic esophagitis
Sanofi, Regeneron get FDA breakthrough therapy status for Dupixent to treat eosinophilic esophagitis
Pharmaceutical Business Review
Mon, 09/14/20 - 10:50 am
Sanofi
Regeneron
Dupixent
FDA
eosinophilic esophagitis
breakthrough status
AstraZeneca’s Fasenra gets FDA ODD status for eosinophilic oesophagitis
Pharmaceutical Business Review
Thu, 08/29/19 - 10:28 am
AstraZeneca
Fasenra
orphan drugs
FDA
eosinophilic esophagitis
Merck KGaA spinout Calypso raises €20M series A
BioCentury
Wed, 02/20/19 - 07:57 pm
Calypso Biotech
eosinophilic esophagitis
CALY-002
Regeneron-Sanofi food allergy drug succeeds mid-stage study
Yahoo/Reuters
Mon, 10/16/17 - 09:50 am
Regeneron
Amgen
food allergies
eosinophilic esophagitis
Dupixent